Dr Sherin Bakhashab
Rosie Barber
Josie O'Neill
Dr Catherine Arden
Dr Jolanta Weaver
| Overexpression of miR-199b-5p in Colony Forming Unit-Hill’s Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression | 2024 |
|
Dr Sherin Bakhashab
Josie O'Neill
Rosie Barber
Dr Catherine Arden
Dr Jolanta Weaver
| Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin Therapy | 2024 |
|
Jason Phowira
Nicholas Vennart
Dr Jolanta Weaver
| Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up | 2022 |
|
Jason Phowira
Dr Sherin Bakhashab
Anuradha Doddaballapur
Dr Jolanta Weaver
| Subclinical Thyrotoxicosis and Cardiovascular Risk: Assessment of Circulating Endothelial Progenitor Cells, Proangiogenic Cells, and Endothelial Function | 2022 |
|
Nicholas Vennart
Dr Jolanta Weaver
Dr Salman Razvi
| The prevalence and significance of non-uniform thyroid radio-isotope uptake in patients with Graves’ disease | 2022 |
|
Jason Phowira
Dr Fahad Ahmed
Dr Sherin Bakhashab
Dr Jolanta Weaver
| Upregulated miR-18a-5p in Colony Forming Unit-Hill’s in Subclinical Cardiovascular Disease and Metformin Therapy; MERIT Study | 2022 |
|
Dr Sherin Bakhashab
Jevi Latief
Dr Jolanta Weaver
| MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus) | 2021 |
|
Alice Tamara
Jevi Latief
Dr Jolanta Weaver
| Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health | 2021 |
|
Sabby Ray
Alice Tamara
Jevi Latief
Dr Sherin Bakhashab
Dr Jolanta Weaver
| The role of miR-342 in vascular health. Study in subclinical cardiovascular disease in mononuclear cells, plasma, inflammatory cytokines and PANX2 | 2020 |
|
Professor Philip Preshaw
Dr John Taylor
Dr Katrin Jaedicke
Dr Susan Bissett
Paiboon Jitprasertwong
et al. | Treatment of periodontitis reduces systemic inflammation in type 2 diabetes | 2020 |
|
Dr Arjola Bano
Dr Earn Gan
Dr Jolanta Weaver
Dr Salman Razvi
| Age may influence the impact of TRAbs on thyroid function and relapse-risk in patients with Graves’ disease | 2018 |
|
Dr Fahad Ahmed
Dr Sherin Bakhashab
INDA Bastaman
Dr Rachel Crossland
Dr Michael Glanville
et al. | Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study | 2018 |
|
Dr Sherin Bakhashab
Dr Fahad Ahmed
Dr Michael Glanville
Dr Jolanta Weaver
| Proangiogenic effect of metformin in endothelial cells is via upregulation of VEGFR1/2 and their signaling under hyperglycemia-hypoxia | 2018 |
|
Dr Andy Colman
Dr Jolanta Weaver
| Use of Quick Response (QR) coded bracelets and cards for the improvement of cortisol deficiency/Addison's disease management: an audit of quality of care of the management of steroid deficiency in acute illness | 2018 |
|
Dr Fahad Ahmed
Rachel Rider
Dr Michael Glanville
Dr Salman Razvi
Dr Jolanta Weaver
| Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study | 2016 |
|
